These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 867482)

  • 21. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evaluation of the pregnancy-linked down-regulation of the paternal antigen-specific splenic cytotoxic T lymphocyte activity in allogeneically pregnant mice.
    Parvin M; Isobe K; Goto S; Nakashima I; Tomoda Y
    Microbiol Immunol; 1992; 36(7):757-65. PubMed ID: 1406378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination.
    Kastner DL; Rich RR
    J Immunol; 1978 Nov; 121(5):1732-7. PubMed ID: 712063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do donor cells function as veto cells in the induction and maintenance of tolerance across an MHC disparity in mixed lymphoid radiation chimeras?
    Pierce GE; Watts LM
    Transplantation; 1993 Apr; 55(4):882-7. PubMed ID: 8475564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a cell-surface antigen selectively expressed on the natural killer cell.
    Glimcher L; Shen FW; Cantor H
    J Exp Med; 1977 Jan; 145(1):1-9. PubMed ID: 187714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the immune response in experimental models of autoimmune disorders: resistance of (NZB X NZW)F1 mice to tolerance induction in vivo.
    Zan-Bar I; Barzilay M; Moscovitch M; Slavin S
    Clin Exp Immunol; 1983 Mar; 51(3):558-64. PubMed ID: 6851246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
    Herberman RB; Nunn ME; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immune responses in murine pregnancy. II. Kinetics and nature of the response in females preimmunized against paternal alloantigens.
    Roe R; Bell SC
    Immunology; 1982 May; 46(1):23-30. PubMed ID: 7076280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intrasplenic injection of allogeneic bone marrow cells on the survival of lethally X-irradiated mice.
    Imamura M; Miyazaki T; Okabe M; Sakurada K; Musashi M; Kawamura K; Hatakeyama M
    Transplantation; 1983 Jan; 35(1):19-24. PubMed ID: 6337432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets.
    Johnson ED; Cole GA
    J Exp Med; 1975 Apr; 141(4):866-81. PubMed ID: 47887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the immune response in experimental models of autoimmune disorders: I. Immunocompetence and transplantation tolerance in female (NZB X NZW)F1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras.
    Moscovitch M; Slavin S
    J Clin Lab Immunol; 1983 Apr; 10(4):185-91. PubMed ID: 6345783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cytotoxic effector cells in the mouse mammary tumor system.
    Lane MA; Roubinian J; Slomich M; Trefts P; Blair PB
    J Immunol; 1975 Jan; 114(1 Pt 1):24-9. PubMed ID: 46242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.